"Make Yourself Un-NIMBY-able": Stakeholder Perspectives on Strategies to Mobilize Public and Political Support for Overdose Prevention Centers in the United States of America

Overview

Journal Harm Reduct J

Publisher Biomed Central

Specialties Pharmacology
Psychiatry

Date 2024 Feb 14

PMID 38355641

Authors

Joseph G Rosen

Erin Thompson

Jessica Tardif

Alexandra B Collins

Brandon D L Marshall

Ju Nyeong Park

Affiliations

Soon will be listed here.

Abstract

Background: Overdose prevention centers (OPCs), also known as supervised injection facilities and safe consumption sites, are evidenced-based interventions for preventing overdose deaths and drug-related morbidities. The pathways to legalizing OPCs in the USA have confronted multiple social, political, and legal obstacles. We conducted a multi-site, qualitative study to explore heterogeneities in these pathways in four jurisdictions, as well as to understand stakeholder perspectives on valuable strategies for galvanizing political and public support for OPCs.

Methods: From July 2022 to February 2023, we conducted 17 semi-structured, in-depth interviews with OPC policymakers, service providers, advocates, and researchers from California, New York City, Philadelphia, and Rhode Island, where efforts have been undertaken to authorize OPCs. Using inductive thematic analysis, we identified and compared contextually relevant, salient approaches for increasing support for OPCs.

Results: Participants described several strategies clustering around five distinct domains: (1) embedding OPC advocacy into broader overdose prevention coalitions to shape policy dialogs; (2) building rapport with a plurality of powerbrokers (e.g., lawmakers, health departments, law enforcement) who could amplify the impact of OPC advocacy; (3) emphasizing specific benefits of OPCs to different audiences in different contexts; (4) leveraging relationships with frontline workers (e.g., emergency medicine and substance use treatment providers) to challenge OPC opposition, including 'NIMBY-ism,' and misinformation; and (5) prioritizing transparency in OPC decision-making to foster public trust.

Conclusion: While tailored to the specific socio-political context of each locality, multiple OPC advocacy strategies have been deployed to cultivate support for OPCs in the USA. Advocacy strategies that are multi-pronged, leverage partnerships with stakeholders at multiple levels, and tailor communications to different audiences and settings could yield the greatest impact in increasing support for, and diffusing opposition to, future OPC implementation.

Citing Articles

Envisioning the Evolution of Substance Use Services: Social Work and the Establishment of Overdose Prevention Centers.

Steen J, Monteiro C J Soc Work Pract Addict. 2025; 24(4):425-431.

PMID: 40041141 PMC: 11879254. DOI: 10.1080/1533256X.2024.2423925.

"Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking in the United States.

Koehm K, Rosen J, Yedinak Gray J, Tardif J, Thompson E, Park J Subst Use Addctn J. 2024; 45(4):682-689.

PMID: 38804608 PMC: 11458346. DOI: 10.1177/29767342241253663.

References

Rouhani S, White R, Park J, Sherman S . High willingness to use overdose prevention sites among female sex workers in Baltimore, Maryland. Drug Alcohol Depend. 2020; 212:108042. PMC: 9426862. DOI: 10.1016/j.drugalcdep.2020.108042. View

Unick G, Ciccarone D . US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. Int J Drug Policy. 2017; 46:112-119. PMC: 5722230. DOI: 10.1016/j.drugpo.2017.06.003. View

Zibbell J, Clarke S, Kral A, Richardson N, Cauchon D, Aldridge A . Association between law enforcement seizures of illicit drugs and drug overdose deaths involving cocaine and methamphetamine, Ohio, 2014-2019. Drug Alcohol Depend. 2022; 232:109341. DOI: 10.1016/j.drugalcdep.2022.109341. View

Hathaway A, Tousaw K . Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver. Int J Drug Policy. 2008; 19(1):11-6. DOI: 10.1016/j.drugpo.2007.11.006. View

Zibbell J, Aldridge A, Cauchon D, Defiore-Hyrmer J, Conway K . Association of Law Enforcement Seizures of Heroin, Fentanyl, and Carfentanil With Opioid Overdose Deaths in Ohio, 2014-2017. JAMA Netw Open. 2019; 2(11):e1914666. PMC: 6902770. DOI: 10.1001/jamanetworkopen.2019.14666. View

Jenkins E, Slemon A, Morris H, Hyshka E, Schulz P, Haines-Saah R . Bereaved mothers' engagement in drug policy reform: A multisite qualitative analysis. Int J Drug Policy. 2020; 91:103011. DOI: 10.1016/j.drugpo.2020.103011. View

Park J, Sherman S, Rouhani S, Morales K, McKenzie M, Allen S . Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston. J Urban Health. 2019; 96(3):353-366. PMC: 6565790. DOI: 10.1007/s11524-019-00365-1. View

Barry C, Sherman S, Stone E, Kennedy-Hendricks A, Niederdeppe J, Linden S . Arguments supporting and opposing legalization of safe consumption sites in the U.S. Int J Drug Policy. 2018; 63:18-22. DOI: 10.1016/j.drugpo.2018.10.008. View

McGinty E, Barry C, Stone E, Niederdeppe J, Kennedy-Hendricks A, Linden S . Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 2018; 111:73-77. DOI: 10.1016/j.ypmed.2018.02.026. View

10.

Kral A, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P . Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 2010; 110(1-2):160-3. PMC: 2885552. DOI: 10.1016/j.drugalcdep.2010.02.009. View

11.

Downing M, Riess T, Vernon K, Mulia N, Hollinquest M, McKnight C . What's community got to do with it? Implementation models of syringe exchange programs. AIDS Educ Prev. 2005; 17(1):68-78. PMC: 1510902. DOI: 10.1521/aeap.17.1.68.58688. View

12.

Gladden R, Martinez P, Seth P . Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014. MMWR Morb Mortal Wkly Rep. 2016; 65(33):837-43. DOI: 10.15585/mmwr.mm6533a2. View

13.

Pear V, Ponicki W, Gaidus A, Keyes K, Martins S, Fink D . Urban-rural variation in the socioeconomic determinants of opioid overdose. Drug Alcohol Depend. 2018; 195:66-73. PMC: 6375680. DOI: 10.1016/j.drugalcdep.2018.11.024. View

14.

Rouhani S, Schneider K, Weicker N, Whaley S, Morris M, Sherman S . NIMBYism and Harm Reduction Programs: Results from Baltimore City. J Urban Health. 2022; 99(4):717-722. PMC: 9154206. DOI: 10.1007/s11524-022-00641-7. View

15.

Bouvier B, Elston B, Hadland S, Green T, Marshall B . Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J. 2017; 14(1):13. PMC: 5319157. DOI: 10.1186/s12954-017-0139-0. View

16.

Sherman S, Rouhani S, White R, Weicker N, Morris M, Schneider K . Acceptability of Overdose Prevention Sites in the Business Community in Baltimore, Maryland. J Urban Health. 2022; 99(4):723-732. PMC: 9129898. DOI: 10.1007/s11524-022-00647-1. View

17.

Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B . Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014; 145:48-68. DOI: 10.1016/j.drugalcdep.2014.10.012. View

18.

Kral A, Davidson P . Addressing the Nation's Opioid Epidemic: Lessons from an Unsanctioned Supervised Injection Site in the U.S. Am J Prev Med. 2017; 53(6):919-922. DOI: 10.1016/j.amepre.2017.06.010. View

19.

Kral A, Lambdin B, Wenger L, Davidson P . Evaluation of an Unsanctioned Safe Consumption Site in the United States. N Engl J Med. 2020; 383(6):589-590. DOI: 10.1056/NEJMc2015435. View

20.

Salmon A, Thein H, Kimber J, Kaldor J, Maher L . Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?. Int J Drug Policy. 2007; 18(1):46-53. DOI: 10.1016/j.drugpo.2006.11.010. View